| Dr Marshall R Johnson Jr, MD | |
|
355 New Shackle Island Rd, Hendersonville, TN 37075-2300 | |
| (615) 338-1000 | |
| (615) 338-1101 |
| Full Name | Dr Marshall R Johnson Jr |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 30 Years |
| Location | 355 New Shackle Island Rd, Hendersonville, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124007984 | NPI | - | NPPES |
| 3884900 | Medicaid | TN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RA0401X | Internal Medicine - Addiction Medicine | MD37449 (Tennessee) | Secondary |
| 207R00000X | Internal Medicine | MD37449 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Tristar Hendersonville Medical Center | Hendersonville, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hospital Medicine Services Of Tn Llc | 2365807633 | 203 |
| Spero Health Of Tennessee, Llc | 0941683593 | 16 |
News Archive
UIC is part of a national phase 2 clinical trial to evaluate the safety and tolerability of using cells derived from multipotent umbilical cord cells to treat age-related macular degeneration, the most common cause of vision loss in people over 55.
The US Food and Drug Administration have approved the monoclonal antibody raxibacumab for treatment of inhalational anthrax, caused by breathing in spores of Bacillus anthracis.
The "21 for 21" ritual, where 21st birthday revelers attempt to down 21 alcoholic drinks, is highly prevalent among college students, according to new research. In the largest study of its kind, researchers at the University of Missouri determined that many college students drink to excess on their 21st birthdays and potentially jeopardize their health.
Inhibikase Therapeutics, Inc. announces the receipt of a Phase II SBIR grant in the amount of $1.54 million dollars from the U.S. National Institutes of Health to advance its novel Re-engineering with Metabolism Preserved (RAMP) medicinal chemistry program.
› Verified 7 days ago
| Entity Name | Spero Health Of Tennessee, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538628904 PECOS PAC ID: 0941683593 Enrollment ID: O20220816000418 |
News Archive
UIC is part of a national phase 2 clinical trial to evaluate the safety and tolerability of using cells derived from multipotent umbilical cord cells to treat age-related macular degeneration, the most common cause of vision loss in people over 55.
The US Food and Drug Administration have approved the monoclonal antibody raxibacumab for treatment of inhalational anthrax, caused by breathing in spores of Bacillus anthracis.
The "21 for 21" ritual, where 21st birthday revelers attempt to down 21 alcoholic drinks, is highly prevalent among college students, according to new research. In the largest study of its kind, researchers at the University of Missouri determined that many college students drink to excess on their 21st birthdays and potentially jeopardize their health.
Inhibikase Therapeutics, Inc. announces the receipt of a Phase II SBIR grant in the amount of $1.54 million dollars from the U.S. National Institutes of Health to advance its novel Re-engineering with Metabolism Preserved (RAMP) medicinal chemistry program.
› Verified 7 days ago
| Entity Name | Hospital Medicine Services Of Tn Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982301065 PECOS PAC ID: 2365807633 Enrollment ID: O20230421000177 |
News Archive
UIC is part of a national phase 2 clinical trial to evaluate the safety and tolerability of using cells derived from multipotent umbilical cord cells to treat age-related macular degeneration, the most common cause of vision loss in people over 55.
The US Food and Drug Administration have approved the monoclonal antibody raxibacumab for treatment of inhalational anthrax, caused by breathing in spores of Bacillus anthracis.
The "21 for 21" ritual, where 21st birthday revelers attempt to down 21 alcoholic drinks, is highly prevalent among college students, according to new research. In the largest study of its kind, researchers at the University of Missouri determined that many college students drink to excess on their 21st birthdays and potentially jeopardize their health.
Inhibikase Therapeutics, Inc. announces the receipt of a Phase II SBIR grant in the amount of $1.54 million dollars from the U.S. National Institutes of Health to advance its novel Re-engineering with Metabolism Preserved (RAMP) medicinal chemistry program.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Marshall R Johnson Jr, MD 355 New Shackle Island Rd, Hendersonville, TN 37075-2300 Ph: (615) 338-1000 | Dr Marshall R Johnson Jr, MD 355 New Shackle Island Rd, Hendersonville, TN 37075-2300 Ph: (615) 338-1000 |
News Archive
UIC is part of a national phase 2 clinical trial to evaluate the safety and tolerability of using cells derived from multipotent umbilical cord cells to treat age-related macular degeneration, the most common cause of vision loss in people over 55.
The US Food and Drug Administration have approved the monoclonal antibody raxibacumab for treatment of inhalational anthrax, caused by breathing in spores of Bacillus anthracis.
The "21 for 21" ritual, where 21st birthday revelers attempt to down 21 alcoholic drinks, is highly prevalent among college students, according to new research. In the largest study of its kind, researchers at the University of Missouri determined that many college students drink to excess on their 21st birthdays and potentially jeopardize their health.
Inhibikase Therapeutics, Inc. announces the receipt of a Phase II SBIR grant in the amount of $1.54 million dollars from the U.S. National Institutes of Health to advance its novel Re-engineering with Metabolism Preserved (RAMP) medicinal chemistry program.
› Verified 7 days ago
Dr. Disha Awasthi, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 102 Wessington Pl, Hendersonville, TN 37075 Phone: 615-822-2214 Fax: 615-822-6519 | |
Hailu T Kabtimer, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 919 W Main St M3, Hendersonville, TN 37075 Phone: 615-826-2102 Fax: 615-826-2743 | |
Mr. Scott Alan Hande, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 107 Glen Oak Blvd, Suite 202, Hendersonville, TN 37075 Phone: 615-826-0710 Fax: 615-826-0910 | |
Jung H. Lee, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 353 New Shackle Island Rd, #300c, Hendersonville, TN 37075 Phone: 615-338-3337 Fax: 615-338-3329 | |
Paul S Daugherty, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 107 Imperial Blvd, Suite 5, Hendersonville, TN 37075 Phone: 615-826-3111 Fax: 615-826-3112 | |
Dr. Pascal A. Dauphin, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 107 Glen Oak Blvd Ste 201b, Hendersonville, TN 37075 Phone: 615-499-4545 Fax: 615-499-4546 |